-

AAVE Price Surges as Coinbase Tokenized Stocks Launch on Aave V4
AAVE price climbed to around $146 as Aave launched its V4 Equities Hub on Base, allowing eligible users to use Coinbase tokenized stocks like AAPL, AMZN, and GOOGL as collateral for USDC loans. This marks a major step in bridging traditional finance and DeFi.
-

Solana ETF Inflows Hit Record $80M: What It Means
US spot Solana ETFs just recorded a record $80M single-day inflow, signaling growing institutional confidence in SOL. Here’s what this milestone means for crypto investors and the broader altcoin market.
-

XRP Price Prediction After SEC Crypto Clarity Push
XRP surged to $1.54 as the SEC launched a new crypto clarity initiative after the CLARITY Act failed in the Senate. With Bitcoin holding above $84,000 and fresh regulatory guidance on the way, analysts are watching key price levels for XRP’s next move.
-

Pete Hegseth’s Coinbase Bitcoin Gains: What It Means for Crypto Adoption
U.S. Defense Secretary Pete Hegseth’s OGE filing revealed that his Coinbase-held Bitcoin generated between $2,702 and $6,000 in capital gains in 2025. The disclosure highlights growing crypto adoption within government circles and reinforces the legitimacy of regulated exchanges.
-

Bitcoin ETFs Surge: Nearly $3B Inflows in 6 Days
Bitcoin ETFs have attracted nearly $3 billion in inflows over just six days, marking one of their strongest streaks since launch. The surge signals renewed institutional confidence and growing mainstream adoption of crypto as a portfolio asset.
-

SEC Clarifies Staked Ethereum Rules: What Liquid Staking Means
The SEC has clarified that liquid staking tokens backed by Ethereum are not securities as long as they remain pure receipts for staked ETH. The new guidance brings long-awaited clarity to one of DeFi’s largest sectors, though caveats around rehypothecation and marketing claims remain.
-

Canary Capital Updates Staked Injective ETF: INJ Price Rally Ahead?
Canary Capital has amended its staked Injective ETF filing with the SEC, sparking a 5% INJ price rebound. Discover what changed in the prospectus, why investors are excited, and what the approval timeline could look like.
